Saturday, September 30, 2017
Chart[62] - SIA Eng
The counter saw strong buying volume on last trading day. It broke up
from 3.45. Next stronger resistance could be ~ 3.6 shall buying
interest continues. Shall it fall back 3.37, the uptrend could be failed
in formation.
Friday, September 29, 2017
Oct[2] - Cash is King
The following counters were shortlisted for their net cash position
(insignificant debt). China Aviation Oil, Golden Energy and ISDN have
been producing strong improvement in earning year to date. Coming
quarters could see Silverlake recovering from declining earning as well.
Recent price weakness among them might present hunting opportunity
before 3rd quarter result announcement.
Oct[1] - Market Updates
Singapore:
STI has retreated about 5% from its 2017 peak. It's gaining support ~ 3193, but fails to break up 3250 so far. Trend look stagnant for meantime. Such correction is actually reasonable considering its bullishness in first half year. Investor could take position through STI ETF (listed in SGX) before next rally.
Market Calendar on coming week:
(SG: Singapore; CH: China; UK: United Kingdom; US: USA; JP: Japan).
STI has retreated about 5% from its 2017 peak. It's gaining support ~ 3193, but fails to break up 3250 so far. Trend look stagnant for meantime. Such correction is actually reasonable considering its bullishness in first half year. Investor could take position through STI ETF (listed in SGX) before next rally.
Market Calendar on coming week:
(SG: Singapore; CH: China; UK: United Kingdom; US: USA; JP: Japan).
Friday, September 22, 2017
Sep[9] - STI Book Value Hunt
The following counters were shortlisted from STI because they are trading below respective book or equity value.
Sep[8] - Market Updates
Crude Oil:
Oil price has been in short rally over last two weeks. Price is close to two years resistance ~ USD52~55. Latest OPEC meeting didn't come to any conclusion on any production freeze or extension from previous cut. Refineries in US has been back to operation upon hurricane attack. Coming weeks' oil inventory data in US shall determine the direction of crude oil.
Trade on bullish Oil: Oil ETF (ticker: DBO)
Trade on bearish Oil: Inverse Oil ETF (ticker: SCO)
Market Calendar on coming week:
(SG: Singapore; CH: China; UK: United Kingdom; US: USA; JP: Japan).
Oil price has been in short rally over last two weeks. Price is close to two years resistance ~ USD52~55. Latest OPEC meeting didn't come to any conclusion on any production freeze or extension from previous cut. Refineries in US has been back to operation upon hurricane attack. Coming weeks' oil inventory data in US shall determine the direction of crude oil.
Trade on bullish Oil: Oil ETF (ticker: DBO)
Trade on bearish Oil: Inverse Oil ETF (ticker: SCO)
(SG: Singapore; CH: China; UK: United Kingdom; US: USA; JP: Japan).
Friday, September 15, 2017
Chart[61] - Singapore O&G
The counter saw some significant buying volume on end Aug and mid Sep
as highlighted in upper chart below. Price moving in a small upward
channel. 0.5 is immediate resistance, shall buying interest continue.
Looking
into its weekly chart (lower), price is capped between between 0.44 and
048. Shall price break down from 0.44, downward trend could continue.
Sep[7] - Raffles Medical
COUNTER: RAFFLES MEDICAL GROUP LTD
OVERVIEW:
The Group is a leading integrated private healthcare provider in Asia, operating medical facilities in 13 cities in SG, China, Japan, Vietnam and Cambodia. From primary care at its network of Raffles Medical clinics to specialist and tertiary care at Raffles Hospital, the Group prides itself on offering a seamless continuum of care to all its patients.
HIGHLIGHTS:
[1] Latest results saw 1H2017 revenue hit 235m and net profit 31m, both are flat year on year.
[2] RafflesMedical continued to expand its network of clinics in SG. While 3 clinics are undergoing relocation and refurbishment, 5 are going to reopen by 3Q2017 with 1 new opening in Hillion Mall. RafflesHospital's Emergency Care Collaboration with Ministry of Health was extended for another 5 years. New RafflesHospital Extension will open in 4Q2017.
[3] Cash and cash equivalent registered at $112m. After deducting borrowing, it is in net cash position of $60m.
INVESTMENT THEMES:
[1] 1H Earning per shares - 0.0185 || Dividend ~ 0.02
Last trading price, 1.1 translates to PE ~ 30 and dividend yield ~ 2%, which is in average valuation among its peers in the region.
[2] In China, 700-bed Raffles Hospital Chongqing and 400-bed RafflesHospital Shanghai are targeted to be operational by 2H2018 and 2H2019 respectively. The Group has a clear growth plan out of domestic market.
PRICE TREND:
The counter has been facing headwind since end of July. Downfall near to 20% in the period. Strong buying volume appeared on mid Sep. Its major shareholder, Standard Life Aberdeen plc raised its stakes to > 6% on 8 Sep as highlighted below. Downtrend could have paused, with support ~ 1.04. Resistance ~ 1.16. Chances for accumulation might be now.
OVERVIEW:
The Group is a leading integrated private healthcare provider in Asia, operating medical facilities in 13 cities in SG, China, Japan, Vietnam and Cambodia. From primary care at its network of Raffles Medical clinics to specialist and tertiary care at Raffles Hospital, the Group prides itself on offering a seamless continuum of care to all its patients.
HIGHLIGHTS:
[1] Latest results saw 1H2017 revenue hit 235m and net profit 31m, both are flat year on year.
[2] RafflesMedical continued to expand its network of clinics in SG. While 3 clinics are undergoing relocation and refurbishment, 5 are going to reopen by 3Q2017 with 1 new opening in Hillion Mall. RafflesHospital's Emergency Care Collaboration with Ministry of Health was extended for another 5 years. New RafflesHospital Extension will open in 4Q2017.
[3] Cash and cash equivalent registered at $112m. After deducting borrowing, it is in net cash position of $60m.
INVESTMENT THEMES:
[1] 1H Earning per shares - 0.0185 || Dividend ~ 0.02
Last trading price, 1.1 translates to PE ~ 30 and dividend yield ~ 2%, which is in average valuation among its peers in the region.
[2] In China, 700-bed Raffles Hospital Chongqing and 400-bed RafflesHospital Shanghai are targeted to be operational by 2H2018 and 2H2019 respectively. The Group has a clear growth plan out of domestic market.
PRICE TREND:
The counter has been facing headwind since end of July. Downfall near to 20% in the period. Strong buying volume appeared on mid Sep. Its major shareholder, Standard Life Aberdeen plc raised its stakes to > 6% on 8 Sep as highlighted below. Downtrend could have paused, with support ~ 1.04. Resistance ~ 1.16. Chances for accumulation might be now.
Subscribe to:
Posts (Atom)